By continuing your visit to this site, you accept the use of cookies. These ensure the smooth running of our services. Learn more.

Jun 01, 2006

MEDGADGET: Neurotechnology Provides Hope for the Paralyzed

 Via Medgadget



Cyberkinetics Neurotechnology Systems Inc. is currently focused on the commercialization of two proprietary platforms for neural stimulation, neural sensing in the brain and real-time neural signal decoding technology. These unique and powerful platforms can restore sensation, communication, limb movement as well as other bodily functions.




The BrainGate™ Neural Interface System is currently the subject of a pilot clinical trial being conducted under an Investigational Device Exemption (IDE) from the FDA. The system is designed to restore functionality for a limited, immobile group of severely motor-impaired individuals. It is expected that people using the BrainGate™ System will employ a personal computer as the gateway to a range of self-directed activities. These activities may extend beyond typical computer functions (e.g., communication) to include the control of objects in the environment such as a telephone, a television and lights...


The NeuroPort™ System is an FDA cleared medical device intended for temporary (< 30 days) recording and monitoring of brain electrical activity.


The NeuroPort™ System is based on Cyberkinetics' BrainGate™technology and consists of two parts, the NeuroPort™ Cortical Microelectrode Array (NeuroPort™ Array) and the NeuroPort™ Neural Signal Processor (NeuroPort™ NSP). The NeuroPort™ Array senses action potentials from individual neurons in the brain. The NeuroPort™ NSP records these high resolution signals and provides a physician with the tools to analyze them...


The comments are closed.